United States · 
Who invested in Zylö Therapeutics?
Zylö Therapeutics's investors include New York Angels, VentureSouth and SC Launch.
2020202120222023
$4.0MSeries A$294KGrantUnited States · Funded startup
Who invested in Zylö Therapeutics
2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$4.3Mraised across 2 rounds since 2019, from 2 sources
$4.0MSeries A$294KGrant
- Latest round
- Grant, $294KMay 2023
- Biggest round
- $4.0MSeries A · Sept 2019
- Investors
- 3
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $4.0M Sept 2019
- Biggest round
- $4.0M Series A · Sept 2019
- Between rounds
- 3.6 years from the last two
The rounds
- May 2023
- Sept 2019
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Zylö Therapeutics
How much has Zylö Therapeutics raised?
Zylö Therapeutics has raised $4.3M across 2 rounds since 2019.
When did Zylö Therapeutics last raise?
Zylö Therapeutics's most recent round was a Grant of $294K in May 2023.
What was Zylö Therapeutics's biggest round?
Zylö Therapeutics's largest round on record is $4.0M (Series A), in Sept 2019.
Who backed Zylö Therapeutics first?
Zylö Therapeutics's first round on record, in May 2023, was backed by New York Angels, VentureSouth and SC Launch.
What stage is Zylö Therapeutics at?
Zylö Therapeutics's latest named round is a Grant, in May 2023.
Where is Zylö Therapeutics based?
Zylö Therapeutics is based in the United States.
Companies like Zylö Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.